US Stock MarketDetailed Quotes
RCKT Rocket Pharmaceuticals
- 14.390
- +0.190+1.34%
Close Nov 29 13:00 ET
- 14.920
- +0.530+3.68%
Post 17:01 ET
1.31BMarket Cap-5271P/E (TTM)
14.530High14.150Low500.28KVolume14.200Open14.200Pre Close7.20MTurnover0.70%Turnover RatioLossP/E (Static)91.16MShares32.52552wk High3.98P/B1.02BFloat Cap12.62052wk Low--Dividend TTM71.09MShs Float67.480Historical High--Div YieldTTM2.68%Amplitude7.565Historical Low14.388Avg Price1Lot Size
Rocket Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 8.83%-52.1M | -5.81%-53.82M | 1.22%-56.86M | -9.42%-194.92M | 47.63%-29.34M | -30.30%-57.15M | -30.30%-50.87M | -46.75%-57.56M | -47.03%-178.14M | -81.06%-56.02M |
| Net income from continuing operations | -7.79%-66.72M | -6.00%-69.65M | -6.38%-62.05M | -10.70%-245.6M | 10.59%-59.66M | -7.17%-61.9M | -20.77%-65.7M | -35.72%-58.34M | -31.23%-221.86M | -50.80%-66.72M |
| Depreciation and amortization | 35.82%2.39M | 36.97%2.37M | 34.73%2.25M | 13.28%7.1M | 8.83%1.94M | 8.58%1.76M | 10.54%1.73M | 28.49%1.67M | 16.62%6.27M | -44.18%1.78M |
| Change In working capital | 147.58%2.83M | -18.38%4.36M | 39.04%-4.55M | 121.49%13.46M | 12,563.53%21.53M | -233.72%-5.94M | -9.29%5.34M | -68.62%-7.47M | 279.44%6.08M | 105.35%170K |
| -Change in prepaid assets | 93.86%-286K | -76.97%422K | -232.91%-1.15M | 174.98%2.69M | 301.12%4.66M | -2,302.06%-4.66M | -35.76%1.83M | 122.00%866K | -374.90%-3.59M | -895.53%-2.32M |
| -Change in payables and accrued expense | 379.63%3.17M | 38.56%4.54M | 68.86%-2.41M | 4.89%10.15M | 534.12%15.76M | -124.43%-1.13M | 7.70%3.27M | -1,478.41%-7.75M | 300.41%9.67M | 225.19%2.49M |
| -Change in other current liabilities | 62.00%-57K | -348.95%-595K | -68.94%-990K | 12,440.00%617K | --1.11M | -7,400.00%-150K | --239K | -19,433.33%-586K | -103.73%-5K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 8.83%-52.1M | -5.81%-53.82M | 1.22%-56.86M | -9.42%-194.92M | 47.63%-29.34M | -30.30%-57.15M | -30.30%-50.87M | -46.75%-57.56M | -47.03%-178.14M | -81.06%-56.02M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 63.55%78.92M | 78.25%55.62M | 195.41%35.03M | -41.46%-98.07M | -29.67%-140.81M | 105.64%48.25M | -60.39%31.21M | 41.71%-36.72M | -467.72%-69.33M | -743.89%-108.59M |
| Net PPE purchase and sale | 65.89%-1.59M | 53.47%-1.93M | 32.66%-2.04M | -91.11%-16.47M | -42.37%-4.65M | -825.45%-4.66M | -43.18%-4.15M | -54.58%-3.02M | -11.72%-8.62M | -59.84%-3.26M |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --42.73M | ---- |
| Net investment purchase and sale | 52.16%80.51M | 62.79%57.55M | 210.00%37.07M | 21.11%-81.59M | 8.03%-136.16M | 120.75%52.91M | -56.72%35.35M | 44.79%-33.7M | -489.31%-103.43M | -883.07%-148.05M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 63.55%78.92M | 78.25%55.62M | 195.41%35.03M | -41.46%-98.07M | -29.67%-140.81M | 105.64%48.25M | -60.39%31.21M | 41.71%-36.72M | -467.72%-69.33M | -743.89%-108.59M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.91%176K | 740.66%1.53M | -93.55%1.18M | 34.20%208.4M | -99.64%391K | 541.76%189.49M | -98.94%182K | 24,035.53%18.34M | 312.11%155.29M | 9,445.77%108.44M |
| Net common stock issuance | -99.91%176K | 740.66%1.53M | -93.54%1.18M | 34.20%208.39M | -99.64%391K | 541.76%189.49M | -98.94%182K | 24,026.32%18.34M | 312.11%155.29M | 9,445.77%108.44M |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --7K | --0 | --0 | --0 | --7K | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.91%176K | 740.66%1.53M | -93.55%1.18M | 34.20%208.4M | -99.64%391K | 541.76%189.49M | -98.94%182K | 24,035.53%18.34M | 312.11%155.29M | 9,445.77%108.44M |
| Net cash flow | ||||||||||
| Beginning cash position | -13.93%39.97M | -44.42%36.64M | -59.62%57.28M | -39.39%141.86M | 14.65%227.03M | -75.42%46.44M | -50.02%65.92M | -39.39%141.86M | -21.64%234.04M | -19.82%198.02M |
| Current changes in cash | -85.05%26.99M | 117.10%3.33M | 72.82%-20.64M | 8.24%-84.58M | -202.23%-169.75M | 1,877.56%180.59M | -134.18%-19.48M | 25.65%-75.94M | -42.63%-92.18M | -334.02%-56.17M |
| End cash Position | -70.51%66.96M | -13.93%39.97M | -44.42%36.64M | -59.62%57.28M | -59.62%57.28M | 14.65%227.03M | -75.42%46.44M | -50.02%65.92M | -39.39%141.86M | -39.39%141.86M |
| Free cash flow | 13.13%-53.69M | -1.34%-55.75M | 2.79%-58.89M | -13.19%-211.39M | 42.67%-33.99M | -39.32%-61.8M | -31.19%-55.02M | -47.12%-60.58M | -44.91%-186.76M | -79.74%-59.29M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data